STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating

Behavioural Brain Research

Volumn 163, Issue 2, 2005, Pages 257-264

  Fradley, Rosa L ^a   O'Meara, Gillian F ^a   Newman, Richard J ^a   Andrieux, Annie ^b   Job, Didier ^b   Reynolds, David S ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b INSERM   (France)

Author keywords

Hyperlocomotion; Neuro developmental disorder; NMDA NR1 hypomorphic mice; PPI; Schizophrenia; Sensorimotor gating; STOP KO mice

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROTEIN; STABLE TUBULE ONLY POLYPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HYPERACTIVITY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; ANTIPSYCHOTIC AGENTS; BODY TEMPERATURE; BODY WEIGHT; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ENZYME INHIBITORS; GAIT DISORDERS, NEUROLOGIC; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MOTOR ACTIVITY; NEURAL INHIBITION; PHENCYCLIDINE; RECEPTORS, N-METHYL-D-ASPARTATE; REFLEX, ACOUSTIC; ROTAROD PERFORMANCE TEST; SOMATOSENSORY CORTEX; SWIMMING; TIME FACTORS;

EID: 23744479575     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.05.012     Document Type: Article

References (38)

1. K.M. Abel, S. Jolley, D.R. Hemsley, and M.A. Geyer The influence of schizotypy traits on prepulse inhibition in young healthy controls J Psychopharmacol 18 2004 181 188
2. A. Andrieux, P.A. Salin, M. Vernet, P. Kujala, J. Baratier, and S. Gory-Faure The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioural disorders Genes Devt 16 2002 2350 2364
3. P.W. Baas, and S.R. Heidemann Microtubule reassembly from nucleating fragments during the regrowth of amputated neurites J Cell Biol 103 1986 917 927
4. V.P. Bakshi, N.R. Swerdlow, and M.A. Geyer Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response J Pharmacol Exp Ther 271 1994 787 794
5. F.M. Benes Is the GABA cell a final common pathway for the etiology and treatment of schizophrenia and bipolar disorder? Curr Opin Psych 15 2002 277 278
6. D.L. Braff, M.A. Geyer, and N.R. Swerdlow Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology 156 2001 234 258
7. R. Corbett, F. Camacho, A.T. Woods, L.L. Kerman, R.J. Fishkin, and K. Brooks Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors Psychopharmacology 120 1995 67 74
8. G.E. Duncan, S.S. Moy, A. Perez, D.M. Eddy, W.M. Zinzow, and J.A. Lieberman Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function Behav Brain Res 153 2004 507 519
9. R.S. El-Mallakh, M.A. El-Masri, M.O. Huff, X.P. Li, S. Decker, and R.S. Levy Intracerebroventricular administration of ouabain as a model of mania in rats Bipolar Disord 5 2003 362 365
10. D. Forrest, M. Yuzaki, H.D. Soares, L. Ng, D.C. Luk, and M. Sheng Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death Neuron 13 1994 325 338
11. R.R. Gainetdinov, A.R. Mohn, and M.G. Caron Genetic animal models: focus on schizophrenia Trends Neurosci 24 2001 527 533
12. M.A. Geyer, K.L. McIlwain, and R. Paylor Mouse genetic models for prepulse inhibition: an early review Mol Psych 7 2002 1039 1053
13. M.A. Geyer, and B. Ellenbroek Animal behavior models of the mechanisms underlying antipsychotic atypicality Prog Neuropsychopharmacol Biol Psychiatry 27 2003 1071 1079
14. L. Guillaud, C. Bosc, A. Fourest-Lieuvin, E. Denarier, F. Pirollet, and L. Lafanechere STOP proteins are responsible for the high degree of microtubule stabilization observed in neuronal cells J Cell Biol 142 1998 167 179
15. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1991 1301 1308
16. D.C. Javitt Glutamate as a therapeutic target in psychiatric disorders Mol Psychiatry 9 2004 984 987 979
17. T. Kutsuwada, N. Kashiwabuchi, H. Mori, K. Sakimura, E. Kuyhiya, and K. Araki Molecular diversity of the NMDA receptor channel Nature 358 1992 36 41
18. D.A. Lewis, and J.A. Lieberman Catching up on schizophrenia. Natural history and neurobiology Neuron 28 2000 325 334
19. N. Lijam, R. Paylor, M.P. McDonald, J.N. Crawley, C.X. Deng, and K. Herrup Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1 Cell 90 1997 895 905
20. S. Ludewig, M.A. Geyer, M. Ramseier, F.X. Vollenweider, E. Rechsteiner, and K. Cattapan-Ludewig Information-processing deficits and cognitive dysfunction in panic disorder J Psychiatry Neurosci 30 2005 37 43
21. E.-M. Mandelkow, J. Biernat, G. Drewes, N. Gustke, and B. Trinczek Tau domains, phosphorylation, and interactions with microtubules Neurobiol Aging 16 1995 355 362
22. A. McGhie, and J. Chapman Disorders of attention and perception in early schizophrenia Br J Med Psychol 34 1961 103 116
23. A. Mele, D.N. Thomas, and A. Pert Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity Neuroscience 82 1998 43 58
24. H.Y. Meltzer, L. Arvanitis, D. Bauer, W. Rein Meta-Trial Study Group Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder Am J Psychiatry 161 2004 975 984
25. B. Moghaddam, and B.W. Adams Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352
26. A.R. Mohn, R.R. Gainetdinov, M.G. Caron, and B.H. Koller Mice with reduced NMDA receptor expression display behaviours related to schizophrenia Cell 98 1999 427 436
27. C.G. Parsons, W. Danysz, and G. Quack Glutamate in CNS disorders as a target for drug development: an update Drug News Perspect 11 1998 523 569
28. R. Paylor, and J.N. Crawley Inbred strain differences in prepulse inhibition of the mouse startle response Psychopharmacology (Berl) 132 1997 169 180
29. M.P. Perriol, K. Dujardin, P. Derambure, A. Marcq, J.L. Bourriez, and E. Laureau Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease J Neurol Neurosurg Psychiatry 76 2005 106 108
30. R.J. Ralph, M.P. Paulus, F. Fumagalli, M.G. Caron, and M.A. Geyer Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists J Neurosci 21 2001 305 313
31. F. Sams-Dodd Effects of continuous d-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats Neuropsychopharmacology 19 1998 18 25
32. P. Seeman Dopamine receptors and the dopamine hypothesis of schizophrenia Synapse 1 2 1987 133 152
33. L.S. Seiden, K.E. Sabol, and G.A. Ricaurte Amphetamine: effects on catecholamine systems and behavior Annu Rev Pharmacol Toxicol 33 1993 639 677
34. C. Spielewoy, C. Roubert, M. Hamon, M. Nosten-Bertrand, C. Betancur, and B. Giros Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice Behav Pharmacol 11 2000 279 290
35. N.R. Swerdlow, M.A. Geyer, and D.L. Braff Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges Psychopharmacology 156 2000 194 215
36. P. Tueting, E. Costa, Y. Dwivedi, A. Guidotti, F. Impagnatiello, and R. Manev The phenotypic characteristics of heterozygous reeler mouse Neuroreport 10 1999 1329 1334
37. D.R. Weinberger On the plausibility of the neurodevelopmental hypothesis of schizophrenia Neuropsychopharmacology 14 1996 1S 11S
38. G.K. Wood, H. Tomasiewicz, U. Rutishauser, T. Magnuson, R. Quirion, and J. Rochford NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle Neuroreport 9 1998 461 466